Immunic, Inc. (IMUX) stock
IMUXNasdaqPharmaceutical PreparationsFiscal year ends December 31
$7.39−0.13 (-1.73%)
Close on Nov 19, 2026Market cap $100.83MP/E –Yield 0.00%
Immunic shares outstanding
Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.
Immunic's shares outstanding was 43M at Jun 30, 2026. For fiscal 2025 it was 16M, up 55.4% from the year before. Over ten years it grew 77.4% a year on average. The highest annual figure on record is 16M in fiscal 2025.
Annual shares outstanding
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 16M | +55.4% |
| FY2024 | Dec 31, 2024 | 10M | +126.0% |
| FY2023 | Dec 31, 2023 | 4M | +39.3% |
| FY2022 | Dec 31, 2022 | 3M | +34.5% |
| FY2021 | Dec 31, 2021 | 2M | +51.0% |
| FY2020 | Dec 31, 2020 | 2M | +102.8% |
| FY2019 | Dec 31, 2019 | 1M | +811.8% |
| FY2018 | Dec 31, 2018 | 0M | +6.2% |
| FY2017 | Dec 31, 2017 | 0M | +27.0% |
| FY2016 | Dec 31, 2016 | 0M | +24.8% |
| FY2015 | Dec 31, 2015 | 0M | +56.7% |
| FY2014 | Dec 31, 2014 | 0M | +2975.6% |
| FY2013 | Dec 31, 2013 | 0M | +22.2% |
| FY2012 | Dec 31, 2012 | 0M | – |
Quarterly shares outstanding
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | 43M | +221.6% |
| Q1 FY2026 | Mar 31, 2026 | 30M | +197.4% |
| Q4 FY2025 | Dec 31, 2025 | 19M | +93.0% |
| Q3 FY2025 | Sep 30, 2025 | 19M | +91.5% |
| Q2 FY2025 | Jun 30, 2025 | 13M | +30.5% |
| Q1 FY2025 | Mar 31, 2025 | 10M | +4.2% |
| Q4 FY2024 | Dec 31, 2024 | 10M | +125.8% |
| Q3 FY2024 | Sep 30, 2024 | 10M | +127.2% |
| Q2 FY2024 | Jun 30, 2024 | 10M | +127.9% |
| Q1 FY2024 | Mar 31, 2024 | 10M | +122.8% |
| Q4 FY2023 | Dec 31, 2023 | 4M | +16.4% |
| Q3 FY2023 | Sep 30, 2023 | 4M | +45.8% |
| Q2 FY2023 | Jun 30, 2023 | 4M | +46.9% |
| Q1 FY2023 | Mar 31, 2023 | 4M | +55.2% |
| Q4 FY2022 | Dec 31, 2022 | 4M | +28.0% |
| Q3 FY2022 | Sep 30, 2022 | 3M | +20.7% |
| Q2 FY2022 | Jun 30, 2022 | 3M | +39.1% |
| Q1 FY2022 | Mar 31, 2022 | 3M | +32.8% |
| Q4 FY2021 | Dec 31, 2021 | 3M | +44.2% |
| Q3 FY2021 | Sep 30, 2021 | 3M | +37.6% |
| Q2 FY2021 | Jun 30, 2021 | 2M | +71.3% |
| Q1 FY2021 | Mar 31, 2021 | 2M | +97.0% |
| Q4 FY2020 | Dec 31, 2020 | 2M | +102.5% |
| Q3 FY2020 | Sep 30, 2020 | 2M | +83.6% |
| Q2 FY2020 | Jun 30, 2020 | 1M | +31.3% |
| Q1 FY2020 | Mar 31, 2020 | 1M | +1169.2% |
| Q4 FY2019 | Dec 31, 2019 | 1M | +1110.1% |
| Q3 FY2019 | Sep 30, 2019 | 1M | +1083.4% |
| Q2 FY2019 | Jun 30, 2019 | 1M | +1041.6% |
| Q1 FY2019 | Mar 31, 2019 | 0M | -0.1% |
| Q4 FY2018 | Dec 31, 2018 | 0M | +0.2% |
| Q3 FY2018 | Sep 30, 2018 | 0M | +0.3% |
| Q2 FY2018 | Jun 30, 2018 | 0M | +0.3% |
| Q1 FY2018 | Mar 31, 2018 | 0M | +29.8% |
| Q4 FY2017 | Dec 31, 2017 | 0M | +31.7% |
| Q3 FY2017 | Sep 30, 2017 | 0M | +33.4% |
| Q2 FY2017 | Jun 30, 2017 | 0M | – |
| Q1 FY2017 | Mar 31, 2017 | 0M | – |
| Q4 FY2016 | Dec 31, 2016 | 0M | – |
| Q3 FY2016 | Sep 30, 2016 | 0M | – |
See a number that looks wrong?